Cargando…

Treatment outcomes of biologics and small molecules for chronic hand eczema: An evidence-based systematic review

Detalles Bibliográficos
Autores principales:	Sood, Siddhartha, Akuffo-Addo, Edgar, Georgakopoulos, Jorge R., Mufti, Asfandyar, Maliyar, Khalad, Yeung, Jensen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483057/ https://www.ncbi.nlm.nih.gov/pubmed/37692973 http://dx.doi.org/10.1016/j.jdin.2023.07.016

Ejemplares similares

Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Reply to: “Skin damage among health care workers managing coronavirus disease 2019”
por: Maliyar, Khalad, et al.
Publicado: (2020)

Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Biologic therapy for refractory pemphigoid gestationis: An evidence-based systematic review
por: Sood, Siddhartha, et al.
Publicado: (2023)

Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class
por: Bagit, Ahmed, et al.
Publicado: (2023)

Modifications to dermatology residency education during the COVID-19 pandemic
por: Mufti, Asfandyar, et al.
Publicado: (2020)

Hereditary haemorrhagic telangiectasia: A case report
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review
por: Sachdeva, Muskaan, et al.
Publicado: (2021)

COVID-19 and wound care: A Canadian perspective
por: Mufti, Asfandyar, et al.
Publicado: (2020)

Squamous cell carcinoma arising within discoid lupus erythematous lesions: A systematic review
por: Mufti, Asfandyar, et al.
Publicado: (2020)

Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
por: Georgakopoulos, Jorge R., et al.
Publicado: (2020)

Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

A Systematic Review Characterizing Psoriatic Arthritis Onset and Exacerbation in Patients Receiving Biologic Therapy
por: Sachdeva, Muskaan, et al.
Publicado: (2022)

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

A systematic review of vitiligo onset and exacerbation in patients receiving biologic therapy
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

34223 Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: A multicenter retrospective cohort study
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Hyperkeratotic hand eczema: Eczema or not?
por: Politiek, Klaziena, et al.
Publicado: (2020)

The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2023)

Hand Eczema
por: Agarwal, Uma Shankar, et al.
Publicado: (2014)

Eczema of the Hand
por: Spender, John Kent
Publicado: (1879)

Dermatology: how to manage rosacea in skin of colour
por: Maliyar, Khalad, et al.
Publicado: (2022)

A case report of recalcitrant aphthous ulcers in two patients treated with interleukin-17 inhibitors
por: Ward, Madison, et al.
Publicado: (2021)

Use of risankizumab in two HIV-positive patients with psoriasis
por: Maliyar, Khalad, et al.
Publicado: (2023)

Dermatology: how to manage psoriasis and recognize differences in pathophysiology and presentation in patients with skin of colour
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review
por: Akuffo-Addo, Edgar, et al.
Publicado: (2022)

Drugs Associated With the Development of Palmoplantar Keratoderma: A Systematic Review
por: Mirali, Sara, et al.
Publicado: (2021)

Hand Eczema in the Polish Female Population
por: Polecka, Agnieszka, et al.
Publicado: (2023)

Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Smoking and obesity are associated with chronic hand eczema and severity of hand eczema: Data from the Dutch general population
por: Loman, L., et al.
Publicado: (2022)

Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study
por: Lytvyn, Yuliya, et al.
Publicado: (2021)

Eruptive Seborrheic Keratoses Are Associated With a Co-Occurring Malignancy in the Majority of Reported Cases: A Systematic Review
por: Mirali, Sara, et al.
Publicado: (2021)

Treatment outcomes in patients with papuloerythroderma of Ofuji: A systematic review
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Impact of hand eczema severity on quality of life
por: Charan, Ujwala Priya, et al.
Publicado: (2013)

Alitretinoin for the treatment of severe chronic hand eczema
por: King, Thomas, et al.
Publicado: (2014)

Clinical Features and Awareness of Hand Eczema in Korea
por: Park, Jae Beom, et al.
Publicado: (2016)

Responsiveness and interpretability of the Hand Eczema Severity Index
por: Oosterhaven, J.A.F., et al.
Publicado: (2019)

Alitretinoin Compliance in Patients with Chronic Hand Eczema
por: Seol, Jung Eun, et al.
Publicado: (2021)

Quality of life in patients with chronic hand eczema
por: Bouhamed, M., et al.
Publicado: (2022)

Are There Ethnic Differences in Hand Eczema? A Review
por: Chai, Eleanor Shu Xian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kcb8gvvleba1crgc7i1icsptdm